Literature DB >> 25622007

Structural basis of new allosteric inhibition in Kinesin spindle protein Eg5.

Hideshi Yokoyama1, Jun-ichi Sawada2, Shiori Katoh1, Kenji Matsuno2, Naohisa Ogo2, Yoshinobu Ishikawa1, Hiroshi Hashimoto1, Satoshi Fujii1, Akira Asai2.   

Abstract

Kinesin spindle protein Eg5 is a target for anticancer therapies, and small molecule inhibitors of its ATPase activity have been developed. We herein report for the first time the crystal structure of and biochemical studies on the Eg5 motor domain in complex with a new type of allosteric inhibitor. The biphenyl-type inhibitor PVZB1194 binds to the α4/α6 allosteric pocket 15 Å from the ATP-binding pocket, which differs from conventional allosteric inhibitors that bind to the allosteric L5/α2/α3 pocket of Eg5. Binding of the inhibitor is involved in the neck-linker conformation and also causes conformational changes around the ATP-binding pocket through Tyr104 to affect the interaction of ATP with the pocket. This structure provides useful information for the development of novel types of allosteric drugs as well as a novel insight into the molecular mechanism responsible for regulating the motor activity of kinesins.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25622007     DOI: 10.1021/cb500939x

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  14 in total

1.  Structure-Guided Design of Novel l-Cysteine Derivatives as Potent KSP Inhibitors.

Authors:  Naohisa Ogo; Yoshinobu Ishikawa; Jun-Ichi Sawada; Kenji Matsuno; Akihiro Hashimoto; Akira Asai
Journal:  ACS Med Chem Lett       Date:  2015-07-22       Impact factor: 4.345

Review 2.  Kinesin, 30 years later: Recent insights from structural studies.

Authors:  Weiyi Wang; Luyan Cao; Chunguang Wang; Benoît Gigant; Marcel Knossow
Journal:  Protein Sci       Date:  2015-06-11       Impact factor: 6.725

3.  Eg5 Inhibitors Have Contrasting Effects on Microtubule Stability and Metaphase Spindle Integrity.

Authors:  Geng-Yuan Chen; You Jung Kang; A Sophia Gayek; Wiphu Youyen; Erkan Tüzel; Ryoma Ohi; William O Hancock
Journal:  ACS Chem Biol       Date:  2017-02-22       Impact factor: 5.100

4.  Nucleotide-free kinesin motor domains reversibly convert to an inactive conformation with characteristics of a molten globule.

Authors:  David D Hackney; Marshall S McGoff
Journal:  Arch Biochem Biophys       Date:  2016-08-26       Impact factor: 4.013

5.  S-trityl-L-cysteine, a novel Eg5 inhibitor, is a potent chemotherapeutic strategy in neuroblastoma.

Authors:  Wei Wu; Shao Jingbo; Weijue Xu; Jiangbin Liu; Yiming Huang; Qingfeng Sheng; Zhibao Lv
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

6.  Impact of kinesin Eg5 inhibition by 3,4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell features.

Authors:  Bruna C Guido; Luciana M Ramos; Diego O Nolasco; Catharine C Nobrega; Bárbara Y G Andrade; Aline Pic-Taylor; Brenno A D Neto; José R Corrêa
Journal:  BMC Cancer       Date:  2015-04-14       Impact factor: 4.430

7.  Eg5 inhibitor YL001 induces mitotic arrest and inhibits tumor proliferation.

Authors:  Yufei Wang; Xingyu Wu; Mufeng Du; Xi Chen; Xianling Ning; Hong Chen; Siyuan Wang; Jia Liu; Zhenming Liu; Ridong Li; Ge Fu; Chunguang Wang; Michael A McNutt; Demin Zhou; Yuxin Yin
Journal:  Oncotarget       Date:  2017-06-27

8.  Structural basis of small molecule ATPase inhibition of a human mitotic kinesin motor protein.

Authors:  Hee-Won Park; Zhujun Ma; Haizhong Zhu; Shimin Jiang; Robert C Robinson; Sharyn A Endow
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

9.  Analysis of Biphenyl-Type Inhibitors Targeting the Eg5 α4/α6 Allosteric Pocket.

Authors:  Chunxia Gao; Noel F Lowndes; Leif A Eriksson
Journal:  ACS Omega       Date:  2017-05-05

Review 10.  Recent findings and future directions for interpolar mitotic kinesin inhibitors in cancer therapy.

Authors:  Stephanie M Myers; Ian Collins
Journal:  Future Med Chem       Date:  2016-03-15       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.